Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Daphne Guh

Dados Biográficos

ID5409272
NOMEDaphne Guh
PRENOMESDaphne
SOBRENOMEGuh
ASSINATURAGUH D
AFILIAÇÕESCentre for Health Evaluation and Outcome Sciences
ORCID0000-0002-0209-5520
VERIFICADOSim
TOTAL DE OBRAS13
TOTAL DE CITAÇÕES2
TOTAL COMO AUTOR13
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2000
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H1
  • Impact of the U.S. 2025 tariff policy on Canadian pharmaceutical exports to the U.S

    Open Access•Yufan Hu, Wei Zhang et al.•ARTICLE•Health Policy•2026

    The U.S. government changed the tariff on Canadian pharmaceutical exports from 25% to 35% in August 2025. • The quantitative impact of this tariff on Canadian pharmaceutical exports is unknown. • Domestic pharmaceutical exports to the U.S. will decrease by US$2 billion. • Re-exporting activities through Canada will cease. • Pharmaceutical industry needs support from industrial and pharmaceutical policy. A bilateral tariff on Canadian exports to t…

  • Can patient-reported data improve predictions about who will be a high-need, high-cost patient in British Columbia

    Open Access•Logan Trenaman, Daphne Guh et al.•ARTICLE•Quality of Life Research•2025

  • The impact of changing the reference countries on the list prices for patented medicines in Canada

    Open Access•Wei Zhang, Daphne Guh et al.•ARTICLE•Health Policy•2024

    BACKGROUND: Canada's Patented Medicine Prices Review Board (PMPRB) uses external and internal reference pricing (IRP) to regulate patented drug list prices. PMPRB has changed external reference countries from 7 to 11 to include countries with prices closer to the OECD median. We examined the impact on the list prices for patented medicines had the amendment been implemented from 2013. METHODS: Using IQVIA MIDAS® quarterly sales data, we selected …

  • Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder

    Tianna Magel, Lourdes Atziri Gonzalez Arreola et al.•ARTICLE•Journal of Psychoactive Drugs•2024

    Identifying typical doses of existing opioid use disorder medications, such as injectable opioid agonist treatment (iOAT), can support client and program needs, and potentially increase iOAT expansion. Longitudinal data from participants in a cohort study ( n = 131), along with clinic dispensation records from August 2014 to April 2020, were used to examine physician prescribed as well as used doses of injectable diacetylmorphine and hydromorphon…

  • Quality of life of the Canadian population using the VR-12

    Open Access•Logan Trenaman, Daphne Guh et al.•ARTICLE•Quality of Life Research•2023

    This is the first study to present Canadian norms for the VR-12. Health utility norms can serve as a valuable input for Canadian economic models, while summary component and domain norms can help interpret routinely-collected data

  • Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence

    Eugenia Oviedo‐Joekes, Eugenia Oviedo-Joekes et al.•ARTICLE•JAMA Psychiatry•2016

    clinicaltrials.gov Identifier: NCT01447212.

  • Predictors of treatment allocation guesses in a randomized controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder

    Eugenia Oviedo‐Joekes, Kirsten Marchand et al.•ARTICLE•Addiction Research & Theory•2016

    Background: SALOME (Study to Assess Longer-term Opioid Medication Effectiveness) tested in a double-blind non-inferiority clinical trial if hydromorphone could be as effective as diacetylmorphine for severe opioid use disorder. Although participants did not guess treatment correctly beyond what is expected by chance, perceived treatment assignment could affect patients’ response to treatment. This study tested if treatment allocation guess is ass…

  • Characteristics and Response to Treatment among Aboriginal People Receiving Heroin-assisted Treatment

    Open Access•Eugenia Oviedo‐Joekes, Eugenia Oviedo-Joekes et al.•ARTICLE•Canadian Journal of Public Health•2010•Referências: 13

  • The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/Aids

    Open Access•Bohdan Nosyk, Huiying Sun et al.•ARTICLE•Quality of Life Research•2009

  • Are indirect utility measures reliable and responsive in rheumatoid arthritis patients

    Open Access•Carlo A Marra, Amir Adel Rashidi et al.•ARTICLE•Quality of Life Research•2005

  • A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis

    Carlo A Marra, John M Esdaile et al.•ARTICLE•Medical Care•2004•Referências: 16

    OBJECTIVES: Utility scores can be assessed indirectly using preference-based instruments and used as weightings for quality-adjusted life years in economic analyses. It is not clear whether available instruments yield similar results or what domains of health are contributing to the overall score in a sample of patients with rheumatoid arthritis (RA). SUBJECTS: Our study included 313 individuals with rheumatologist-confirmed RA. MEASURES: A self-…

  • A Dog’s Breakfast

    Aslam H Anis, Daphne Guh et al.•ARTICLE•Medical Care•2001

    BACKGROUND: Each province in Canada independently assesses drugs for their reimbursement eligibility. Publicly funded access to specific drugs is therefore dependent on province of residence. OBJECTIVE: Evaluate the variability of access and its determinants for publicly available prescription drugs across Canada, and discuss the feasibility of implementing a national plan. METHODS: For a sample of 58 drugs receiving Health Protection Branch appr…

  • The Costs of Cardiorespiratory Disease Episodes in a Study of Emergency Department Use

    Open Access•Aslam H Anis, Daphne Guh et al.•ARTICLE•Canadian Journal of Public Health•2000•Citada por: 2•Referências: 14

  • The Costs of Cardiorespiratory Disease Episodes in a Study of Emergency Department Use

    Open Access•Aslam H Anis, Daphne Guh et al.•ARTICLE•Canadian Journal of Public Health•2000•Citada por: 2•Referências: 14

  • The Costs of Cardiorespiratory Disease Episodes in a Study of Emergency Department Use

    Open Access•Aslam H Anis, Daphne Guh et al.•ARTICLE•Canadian Journal of Public Health•2000•Citada por: 2•Referências: 14

  • A Dog’s Breakfast

    Aslam H Anis, Daphne Guh et al.•ARTICLE•Medical Care•2001

    BACKGROUND: Each province in Canada independently assesses drugs for their reimbursement eligibility. Publicly funded access to specific drugs is therefore dependent on province of residence. OBJECTIVE: Evaluate the variability of access and its determinants for publicly available prescription drugs across Canada, and discuss the feasibility of implementing a national plan. METHODS: For a sample of 58 drugs receiving Health Protection Branch appr…

  • A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis

    Carlo A Marra, John M Esdaile et al.•ARTICLE•Medical Care•2004•Referências: 16

    OBJECTIVES: Utility scores can be assessed indirectly using preference-based instruments and used as weightings for quality-adjusted life years in economic analyses. It is not clear whether available instruments yield similar results or what domains of health are contributing to the overall score in a sample of patients with rheumatoid arthritis (RA). SUBJECTS: Our study included 313 individuals with rheumatologist-confirmed RA. MEASURES: A self-…

  • Are indirect utility measures reliable and responsive in rheumatoid arthritis patients

    Open Access•Carlo A Marra, Amir Adel Rashidi et al.•ARTICLE•Quality of Life Research•2005

  • The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/Aids

    Open Access•Bohdan Nosyk, Huiying Sun et al.•ARTICLE•Quality of Life Research•2009

  • Characteristics and Response to Treatment among Aboriginal People Receiving Heroin-assisted Treatment

    Open Access•Eugenia Oviedo‐Joekes, Eugenia Oviedo-Joekes et al.•ARTICLE•Canadian Journal of Public Health•2010•Referências: 13

  • Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence

    Eugenia Oviedo‐Joekes, Eugenia Oviedo-Joekes et al.•ARTICLE•JAMA Psychiatry•2016

    clinicaltrials.gov Identifier: NCT01447212.

  • Predictors of treatment allocation guesses in a randomized controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder

    Eugenia Oviedo‐Joekes, Kirsten Marchand et al.•ARTICLE•Addiction Research & Theory•2016

    Background: SALOME (Study to Assess Longer-term Opioid Medication Effectiveness) tested in a double-blind non-inferiority clinical trial if hydromorphone could be as effective as diacetylmorphine for severe opioid use disorder. Although participants did not guess treatment correctly beyond what is expected by chance, perceived treatment assignment could affect patients’ response to treatment. This study tested if treatment allocation guess is ass…

  • Quality of life of the Canadian population using the VR-12

    Open Access•Logan Trenaman, Daphne Guh et al.•ARTICLE•Quality of Life Research•2023

    This is the first study to present Canadian norms for the VR-12. Health utility norms can serve as a valuable input for Canadian economic models, while summary component and domain norms can help interpret routinely-collected data

  • The impact of changing the reference countries on the list prices for patented medicines in Canada

    Open Access•Wei Zhang, Daphne Guh et al.•ARTICLE•Health Policy•2024

    BACKGROUND: Canada's Patented Medicine Prices Review Board (PMPRB) uses external and internal reference pricing (IRP) to regulate patented drug list prices. PMPRB has changed external reference countries from 7 to 11 to include countries with prices closer to the OECD median. We examined the impact on the list prices for patented medicines had the amendment been implemented from 2013. METHODS: Using IQVIA MIDAS® quarterly sales data, we selected …

  • Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder

    Tianna Magel, Lourdes Atziri Gonzalez Arreola et al.•ARTICLE•Journal of Psychoactive Drugs•2024

    Identifying typical doses of existing opioid use disorder medications, such as injectable opioid agonist treatment (iOAT), can support client and program needs, and potentially increase iOAT expansion. Longitudinal data from participants in a cohort study ( n = 131), along with clinic dispensation records from August 2014 to April 2020, were used to examine physician prescribed as well as used doses of injectable diacetylmorphine and hydromorphon…

  • Can patient-reported data improve predictions about who will be a high-need, high-cost patient in British Columbia

    Open Access•Logan Trenaman, Daphne Guh et al.•ARTICLE•Quality of Life Research•2025

  • Impact of the U.S. 2025 tariff policy on Canadian pharmaceutical exports to the U.S

    Open Access•Yufan Hu, Wei Zhang et al.•ARTICLE•Health Policy•2026

    The U.S. government changed the tariff on Canadian pharmaceutical exports from 25% to 35% in August 2025. • The quantitative impact of this tariff on Canadian pharmaceutical exports is unknown. • Domestic pharmaceutical exports to the U.S. will decrease by US$2 billion. • Re-exporting activities through Canada will cease. • Pharmaceutical industry needs support from industrial and pharmaceutical policy. A bilateral tariff on Canadian exports to t…

Medicine (11 obras) · Health Systems, Economic Evaluations, Quality of Life (7 obras) · Internal Medicine (7 obras) · Statistics (5 obras) · Health related quality of life (4 obras) · Hydromorphone (4 obras) · Internal Medicine (4 obras) · Mathematics (4 obras) · Opioid (4 obras) · Opioid Use Disorder Treatment (4 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae